Delivery Order SPE2DB22D3301-SPE2DB25FZ0YB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for Ultane Liquid 250ML with a ceiling value of $3,202.32. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on May 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ultane 250 ML in pen bottle format. This $1,155.12 firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 8, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,828.94 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles. This firm fixed-price, non-set-aside contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,667.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 4565818463 ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product, with an ultimate completion date of September 17, 2024. The contract is not set aside and serves as a delivery order against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 17, 2025, from the Defense Logistics Agency (DLA) for ULTANE 250 ML in pen bottle format. This firm fixed-price, non-set-aside contract has a ceiling value of $2,310.24 and an ultimate completion date of September 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,780.81 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract, designated as a child order under a larger indefinite delivery contract (IDC), covers the supply of Ultane 250 mL pen bottle medication. This delivery order was competitively awarded with firm fixed-price pricing...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0YBDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ultane 250 ML pen bottles with a ceiling value of $1,347.64. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supporting Defense Health Agency operations and other government healthcare systems through the supply of specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders reflects its established capability to meet federal procurement requirements for essential pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/15/25 |